Dutasteride 0.5mg
Product Overview
| Generic Name | Dutasteride 0.5mg |
| Brand Name(s) | Avodart |
| Category | Antineoplastic / Cancer |
| Form | 30 Oral Capsules |
| Strength | 0.5 g capsules |
| Therapeutic Class | 5a-Reductase inhibitor |
| ATC Code | G04CB02 |
Manufacturing & Regulatory
| Manufacturer | GlaxoSmithKline |
| GMP Compliance | WHO-GMP certified |
| DMF/CEP | Type II/III |
| COFEPRIS | 010.000.5319.00 |
| Free Sale Certificate | Yes |
Logistics & Export
| MOQ | 10 units |
| Shelf Life | 24 months |
| Storage | 20–25 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Yes |
| CTD Summary (PDF) | Public CTD-derived summaries via EMA EPAR/SmPC |
Special Notes
Dutasteride is mainly used to treat benign prostatic hyperplasia (BPH)—an enlarged prostate in men. It helps to:
- Reduce prostate size
- Improve urine flow
- Reduce frequent or difficult urination
- Lower the risk of acute urinary retention
- Reduce the likelihood of prostate-related surgery
It works by blocking the conversion of testosterone into dihydrotestosterone (DHT), a hormone that contributes to prostate enlargement.
Dutasteride is also used for male-pattern hair loss in some countries, but this use is not universally approved.